Being overweight or obese was associated with a greater risk for end-stage renal disease

May 2006
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p78
Academic Journal
The article presents information on a study related to the association of obesity with an increased risk for end-stage renal disease (ESRD). A health maintenance organization in northern California made a cohort study of 320,252 adults. Results of the study were adjusted for age, sex, race, educational level, smoking status, history of myocardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, serum creatinine level, presence of diabetes, and baseline blood pressure. The study found that being overweight or obese could be associated with an increased risk for ESRD in community-dwelling men and women.


Related Articles

  • The rising tide of end-stage renal disease: what can be done? Glassock, Richard J. // Clinical & Experimental Nephrology;Dec2004, Vol. 8 Issue 4, p291 

    The prevalence of end-stage renal disease (ESRD) is rising throughout the developed and developing world, although the rate of increase may be attenuating in some regions. Type 2 diabetes mellitus, often a consequence of obesity and accompanied by the metabolic syndrome, is a major cause of...

  • Overweight people are at risk of end-stage renal disease.  // Nursing Standard;6/21/2006, Vol. 20 Issue 41, p18 

    The article stresses the risk of being overweight for end-stage renal failure. Researchers had studied how obesity relates renal failure where they involved 320,252 adults and had found out that a total of 1,471 cases of end-stage renal disease occurred during the follow-up. Body mass index was...

  • Being overweight or obese was associated with a greater risk for end-stage renal disease: COMMENTARY. O'Hare, Ann M. // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p78 

    The article presents the author's views regarding a study on an association between obesity and end-stage renal disease (ESRD). The study provides evidence that risk factors for ESRD frequently overlap with those for cardiovascular disease and adds to the growing list of adverse outcomes...

  • Chronic kidney disease associated with mortality in Northern Ireland. Quinn, M.; Cardwell, C.; Savage, G.; Maxwell, A. P.; Kee, F.; Fogarty, D. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p63 

    The article discusses a study which aimed to investigate if the increased mortality shown to be associated with chronic kidney disease (CKD) in the U.S. population is also present in Northern Ireland (NI). In this study, all creatinine results in NI between January 1-31, 2001 to December 2002...

  • We don't need no education … . (Pink Floyd, The Wall) Multidisciplinary predialysis education programmes: pass or fail? Van Biesen, Wim; Verbeke, Francis; Vanholder, Raymond // Nephrology Dialysis Transplantation;Nov2009, Vol. 24 Issue 11, p3277 

    The article reports on a study related to the impact of an established Multidisciplinary predialysis education (MPE) programme on the outcome of patients with chronic kidney disease (CKD) stage 3 or higher. As reported the outcome of MPE seems to be different between different studies. In one of...

  • Renal Disease and Failure.  // Kidney;Mar/Apr2004, Vol. 13 Issue 2, p61 

    Discusses several medical studies on renal disease and failure. Incident rate and prognosis of detected chronic kidney disease among elderly poor in Great Britain; Determination of racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the U.S.;...

  • Is hepcidin the star player in iron metabolism in chronic kidney disease? Hamada, Yasuhiro; Fukagawa, Masafumi // Kidney International;May2009, Vol. 75 Issue 9, p873 

    It is well known that abnormal iron metabolism contributes to the development of anemia in chronic kidney disease (CKD) patients. Hepcidin is a circulating peptide produced in the liver that regulates efflux of iron from the cells. Ashby et al. measured the serum level of hepcidin using a new...

  • Comorbidity and confounding in end-stage renal disease. Seliger, Stephen L. // Kidney International;Jan2010, Vol. 77 Issue 2, p83 

    In the epidemiologic study of end-stage renal disease (ESRD), accurate adjustment for comorbidity is essential to controlling bias in the comparison of outcomes across groups of patients or dialysis facilities. Liu et al. derive and validate a novel comorbidity index using data from the United...

  • Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Nii-Kono, T.; Iwasaki, Y.; Uchida, M.; Fujieda, A.; Hosokawa, A.; Motojima, M.; Yamato, H.; Kurokawa, K.; Fukagawa, M. // Kidney International;Apr2007, Vol. 71 Issue 8, p738 

    Skeletal resistance to parathyroid hormone (PTH) is well known to the phenomenon in chronic renal failure patient, but the detailed mechanism has not been elucidated. In the process of analyzing an animal model of renal failure with low bone turnover, we demonstrated decreased expression of PTH...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics